Suppr超能文献

口服耐受 T 细胞中 DNA 甲基化和基因表达的综合分析。

Comprehensive analysis of DNA methylation and gene expression in orally tolerized T cells.

机构信息

Department of Applied Biological Science, Tokyo University of Agriculture and Technology, Fuchu, Tokyo, Japan.

Biostatistics Center, Kurume University, Kurume, Fukuoka, Japan.

出版信息

PLoS One. 2020 Feb 25;15(2):e0229042. doi: 10.1371/journal.pone.0229042. eCollection 2020.

Abstract

T cell anergy is known to be a crucial mechanism for various types of immune tolerance, including oral tolerance. The expression of several anergy-specific genes was reportedly up-regulated in anergic T cells, and played important roles in the cells. However, how the genes were up-regulated has not been understood. In this study, we comprehensively analyzed the altered gene expression and DNA methylation status in T cells tolerized by oral antigen in vivo. Our results showed that many genes were significantly up-regulated in the orally tolerized T cells, and most of the genes found in this study have not been reported previously as anergy related genes; for example, ribosomal protein L41 (FC = 3.54E06, p = 3.70E-09: Fisher's exact test; the same applies hereinafter) and CD52 (FC = 2.18E05, p = 3.44E-06). Furthermore, we showed that the DNA methylation statuses of many genes; for example, enoyl-coenzyme A delta isomerase 3 (FC = 3.62E-01, p = 3.01E-02) and leucine zipper protein 1 (FC = 4.80E-01, p = 3.25E-02), including the ones distinctly expressed in tolerized T cells; for example, latexin (FC = 3.85E03, p = 4.06E-02 for expression; FC = 7.75E-01, p = 4.13E-01 for DNA methylation) and small nuclear ribonucleoprotein polypeptide F (FC = 3.12E04, p = 4.46E-04 for expression; FC = 8.56E-01, p = 5.15E-01 for DNA methylation), changed during tolerization, suggesting that the distinct expression of some genes was epigenetically regulated in the tolerized T cells. This study would contribute to providing a novel clue to the fine understanding of the mechanism for T cell anergy and oral tolerance.

摘要

T 细胞无能被认为是各种类型免疫耐受的关键机制,包括口服耐受。据报道,无能 T 细胞中表达了几种无能特异性基因,这些基因在细胞中发挥重要作用。然而,这些基因是如何上调的还不清楚。在这项研究中,我们全面分析了体内口服抗原耐受的 T 细胞中改变的基因表达和 DNA 甲基化状态。我们的结果表明,许多基因在口服耐受的 T 细胞中显著上调,并且本研究中发现的大多数基因以前没有被报道为与无能相关的基因;例如,核糖体蛋白 L41(FC = 3.54E06,p = 3.70E-09:Fisher 精确检验;以下相同)和 CD52(FC = 2.18E05,p = 3.44E-06)。此外,我们表明许多基因的 DNA 甲基化状态,例如烯酰辅酶 A 差向异构酶 3(FC = 3.62E01,p = 3.01E-02)和亮氨酸拉链蛋白 1(FC = 4.80E-01,p = 3.25E-02),包括在耐受 T 细胞中明显表达的基因;例如,latexin(FC = 3.85E03,p = 4.06E-02 用于表达;FC = 7.75E-01,p = 4.13E-01 用于 DNA 甲基化)和小核核糖核蛋白多肽 F(FC = 3.12E04,p = 4.46E-04 用于表达;FC = 8.56E-01,p = 5.15E-01 用于 DNA 甲基化),在耐受过程中发生变化,表明一些基因的独特表达在耐受 T 细胞中受到表观遗传调控。本研究将有助于为理解 T 细胞无能和口服耐受的机制提供新的线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e8/7041840/e0eec7fddd2e/pone.0229042.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验